SYMBRAVO (NDA215431)- (20MG;EQ 10MG BASE)

Generic Name	MELOXICAM; RIZATRIPTAN BENZOATE	Innovator	AXSOME
Dosage	20MG;EQ 10MG BASE
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2040-May-28	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2028-Jan-30
GAIN Expiry	None	Drug Complexity	No
Indication

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
20MG;EQ 10MG BASE	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of SYMBRAVO